Mobia Medical, Inc.
Nasdaq: MOBINo new filings in 72 h · watching for the next event
Determine whether the company is establishing durable public-market positioning.
Assembled 0s ago · every panel labelled live or simulated · no fabricated metrics
No new filings in 72 h · watching for the next event
Determine whether the company is establishing durable public-market positioning.
Assembled 0s ago · every panel labelled live or simulated · no fabricated metrics
| 2026-08-13 | SCHEDULE 13G | Mobia Medical, Inc. | SEC ↗ |
| 2026-08-11 | 10-Q | 10-Q | SEC ↗ |
| 2026-08-11 | 8-K | 8-K | SEC ↗ |
| 2026-08-03 | 4 | 4 | SEC ↗ |
| 2026-08-03 | 3 | 3 | SEC ↗ |
| 2026-08-03 | 8-K | 8-K | SEC ↗ |
| 2026-07-16 | 4 | 4 | SEC ↗ |
| 2026-07-16 | 3 | 3 | SEC ↗ |
| 2026-07-15 | 8-K | 8-K | SEC ↗ |
| 2026-06-29 | 4 | 4 | SEC ↗ |
| 2026-06-29 | 4 | 4 | SEC ↗ |
Mobia Medical, Inc. is an emerging newly-public company trading at $8.63 with moderate institutional engagement, demonstrated by six Schedule 13D/13G filings and active insider reporting. Fundamentals show reported revenue alongside a net loss, cash on the balance sheet, and positive equity.